Cargando…
Upregulation of Mcl-1S Causes Cell-Cycle Perturbations and DNA Damage Accumulation
As an important regulator of apoptosis, Mcl-1 protein, a member of the Bcl-2 family, represents an attractive target for cancer treatment. The recent development of novel small molecule compounds has allowed Mcl-1-inhibitory therapy to proceed to clinical trials in cancer treatment. However, the pos...
Autores principales: | Streletskaia, Alena Y., Senichkin, Viacheslav V., Prikazchikova, Tatiana A., Zatsepin, Timofei S., Zhivotovsky, Boris, Kopeina, Gelina S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544834/ https://www.ncbi.nlm.nih.gov/pubmed/33072738 http://dx.doi.org/10.3389/fcell.2020.543066 |
Ejemplares similares
-
Bak and Bcl-xL Participate in Regulating Sensitivity of Solid Tumor Derived Cell Lines to Mcl-1 Inhibitors
por: Senichkin, Viacheslav V., et al.
Publicado: (2021) -
Simple and Efficient Protocol for Subcellular Fractionation of Normal and Apoptotic Cells
por: Senichkin, Viacheslav V., et al.
Publicado: (2021) -
The New Face of Autophagy in Chronic Lymphocytic Leukemia
por: Kopeina, Gelina S., et al.
Publicado: (2023) -
Anastasis: Return Journey from Cell Death
por: Zaitceva, Victoria, et al.
Publicado: (2021) -
Drug toxicity assessment: cell proliferation versus cell death
por: Sazonova, Elena V., et al.
Publicado: (2022)